XML 59 R43.htm IDEA: XBRL DOCUMENT v3.25.4
Employee Benefits and Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation
The impact of share-based compensation on the Company’s financial results is presented below:
For the Year Ended December 31,
(In thousands)202520242023
Share-based compensation expense1
$15,742 $13,744 $13,440 
Income tax benefit$(3,990)$(3,483)$(3,406)
1 Excludes $10.3 million in 2023 associated with replacement awards granted in bank acquisitions.
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2025 is presented below:
(In thousands)Unrecognized
Compensation
Cost
Weighted-Average Period Remaining (Years)
RSAs$17,401 1.72
RSUs7,683 2.01
Total$25,084 1.81
Schedule of Nonvested Share Activity
A summary of the status of the Company’s non-vested RSAs as of December 31, 2025, and changes during the year then ended, is presented below:
Restricted
Award
Shares
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2025957,522 $25.47 
Granted612,781 26.36 
Forfeited/Canceled(101,157)25.02 
Vested(443,601)26.68 
Non-vested at December 31, 20251,025,545 $25.52 
A summary of the status of the Company’s non-vested RSUs as of December 31, 2025, and changes during the year then ended, is presented below:
Restricted
Award
Units
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2025521,526 $26.25 
Granted245,375 26.03 
Forfeited/Canceled(82,238)29.51 
Vested(76,968)34.34 
Non-vested at December 31, 2025607,695 $24.70 
Schedule of Restricted Stock and Restricted Stock Units Activity
Information regarding RSAs during each of the following years is presented below:
For the Year Ended December 31,
202520242023
Weighted-average grant date fair value$26.36 $25.00 $24.57 
Fair value of awards vested1
$11,835 $9,813 $8,156 
1Based on grant date fair value, in thousands.
Information regarding RSUs during each of the following years is presented below:
For the Year Ended December 31,
202520242023
Weighted-average grant date fair value$26.03 $25.75 $22.84 
Fair value of awards vested1
$2,643 $3,030 $1,997 
1Based on grant date fair value, in thousands.
Schedule of Stock Option Valuation Assumptions
 For the Year Ended December 31,
202520242023
Risk-free interest rates4.36%N/A4.25%
Expected dividend yield3.09%N/A2.45%
Expected volatility65.23%N/A64.32%
Expected lives (years)5.0N/A1.8
Schedule of Stock Options Roll Forward
A summary of the Company’s stock options as of December 31, 2025, and changes during the year then ended, is presented below:
 OptionsWeighted-Average Exercise Price
Outstanding at January 1, 2025620,642 $22.38 
Granted970 27.79 
Exercised(70,696)13.41 
Expired(1,590)19.51 
Outstanding and Exercisable at December 31, 2025
549,326 $23.58 
Weighted-Average Remaining Contractual Term (Years)1.85
Aggregate Intrinsic Value (000s)
$4,315 
Schedule of Stock Option Activity
The following table presents information related to stock options during each of the following years:
For the Year Ended December 31,
202520242023
Weighted-average grant date fair value$27.79 N/A$12.63 
Intrinsic value of stock options exercised (000s)
$1,199 $2,487 $5,969 
Schedule of Employee Stock Purchase Plan Activity
 202520242023
ESPP shares purchased30,919 32,840 35,630 
Weighted-average employee purchase price$27.23 $24.42 $22.56